Samik Pharmaceutical Company Ltd. logo

Samik Pharmaceutical Company Ltd. (014950)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
5,610. 00
+280
+5.2533%
61.82B Market Cap
- P/E Ratio
- Div Yield
831,651 Volume
- Eps
5,330
Previous Close
Add Transaction
Day Range
5,240 5,910
Year Range
3,705 25,050
Want to track 014950 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Samik Pharmaceutical Company Ltd. (014950) Statistics

Valuation metrics

Market Cap 61.82B
Enterprise value 37.26B
Trailing P/E (ttm) -68.08
Forward P/E -
PEG ratio -
Price/Sales (ttm) 1.08
Price/Book (mrq) -
Enterprise Value/Revenue 0.61
Enterprise Value/EBITDA 8.22

Overview

Shares outstanding 9.17M
Float 2.85M
Shares short -
% Held by insiders 0.63%
% Held by institutions -
Average volume (10 days) 63.47K
Average volume (90 days) 56.11K

Price summary

52-Week low 3,705
52-Week high 25,050
Beta -
50-Day moving average 9,828.8
200-Day moving average 13,672.41

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.01%
Operating margin 0.06%

Operational effectiveness

Return on assets -0.01%
Return on equity -0.01%

Income Statement

Revenue (ttm) 61.48B
Revenue per share (ttm) 7,597.02
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 43.21B
EBITDA 1.06B
Net income to common (ttm) -703.66M
Diluted EPS (ttm) -99
Quarterly earnings growth (yoy) 0.04%

Balance Sheet

Total cash (mrq) 32.02B
Total cash per share (mrq) 3,488.8
Total debt (mrq) 3.01B
Total Debt/Equity (mrq) 4.3
Current ratio (mrq) 4.75%
Book value per share (mrq) -

Cash Flow

Cash flow statement 1.24B
Levered free cash flow (LFCF) -754.89M